USPTO serial 88374592
RHOGEN BIOTECH
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- WELLS, KELLEY L
- Law office
- TMO LAW OFFICE 118- EXAMINING ATTORNEY ASSIGNED
What this means
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
Need help with RHOGEN BIOTECH?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical additives for asphalt; Chemical additives for lubricants; Chemical fertilizers; Chemical getters; Chemical preparations for scientific purposes; Chemical test paper; Enzyme substrates; Enzymes derived from biotechnological processes for use in industry; Enzymes for scientific and research purposes; Enzymes for use in protein hydrolysis; Nutritional additives for use in manufacturing animal feed; Nutritive additive to enhance the biological activity of water, soil, seeds and plants for purposes of fertilization and bioremediation of pollutants; Probiotic compositions for use as ingredients for food and beverages, namely, probiotic bacteria and probiotic bacterial cultures; Protein arrays and nucleotide arrays for scientific and medical research; Protein for industrial use; Protein for use in the manufacture of cosmetics; Protein in raw material form for scientific and medical research; Proteins for the food industry; Proteins for use in manufacture; Proteins for use in the manufacture of food supplements; Proteins for use in the manufacture of detoxification enzymes and drug delivery agents; Active chemical ingredients for use in the manufacture of anti-cancer drugs; Antioxidants and proteins used in the manufacture of cosmetics, beverages, food products and food supplements; Biochemical reagents commonly known as probes, for detecting and analyzing molecules in protein or nucleotide arrays; Biochemicals, namely, monoclonal antibodies for in vitro scientific or research use; Biologically active enzymes and microorganisms that are aimed at sanitising water environments and to treat the activation and optimisation of biological filter systems; Biomedical compounds, namely, peptide substrates used in analyzing and detecting certain toxins for clinical or medical laboratory use; Biomedical compounds, namely, peptide substrates used in analyzing and detecting certain toxins for laboratory or research use; Biostimulants being plant nutrition preparations; Biotechnologically-formed genes for use in the manufacture of agricultural seeds; Biotechnologically-formed genes, microbes and enzymes for use in the production of agricultural seeds to enhance plants' growth therefrom; Chemicals for use in the purification of proteins for in vitro use; Diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents to monitor toxicity of drugs; Kit containing pre-packed columns, chemicals, pre-made buffer concentrates, syringes and instructional manual for the purification of proteins for in vitro use; Laboratory chemicals, namely, an antibody reagent used for the detection of antigens in cell and tissue analysis for in vitro diagnostic use; Leather processing chemical preparations; Microbes for use in the manufacture of enzyme, proteins, antibodies and vaccines; Non-nutritive mixture of protein in the nature of collagen and water for use as an ingredient in the manufacture of food, namely, for forming an edible, external layer on food products during the co-extrusion processing of foodstuffs; Non-nutritive mixture of collagen protein and water for forming an edible casing on food products in co-extrusion food processing; Plant nutrition preparations; Preservatives for use in the manufacture of dietary and nutritional supplements; Reagent kits comprising generic DNA circle, DNA primers, polymerase and buffers for use in biotechnology fields; Test particles for biodetection systems, biological analogues and microscopic carrier beads with chemically attached DNA fragments for use in testing the operation of equipment used for analyzing air for the presence of harmful biological substances; Testing kits containing peptide substrates used in analyzing and detecting certain toxins for clinical or medical laboratory use; Testing kits containing peptide substrates used in analyzing and detecting certain toxins for laboratory or research use; Waterproofing chemical compositions | ACTIVE | Jan 3, 2019 |
| 005 | Chemical contraceptives; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Drug delivery agents in the form of a coating for proteins and probiotics that facilitate the delivery of a wide range of pharmaceuticals; Drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of edible wafers for wrapping powdered pharmaceuticals; Drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of pills, capsules, syrups, liposomes, drug loaded biodegradable microspheres and drug polymer conjugates and liposome-encapsulated agents that facilitate the delivery of pharmaceutical preparations; Drug testing kits comprised of medical diagnostic reagents and assays that test for the presence of bacterial toxins; Enzyme dietary supplements; Enzyme food supplements; Enzyme preparations for medical purposes; Enzymes for medical purposes; Gene therapy products, namely, genetically engineered tissues for transplant purposes; Medicinal drinks; Medicinal herb extracts; Medicinal herbal extracts for medical purposes; Medicinal herbal preparations; Medicinal herbs; Medicinal infusions for treating sepsis, cancer, intestinal disorders, obseity and metabolic disorders; Medicinal preparations for the mouth to be applied in the form of drops, capsules, tablets and compressed tablets; Medicinal preparations for the treatment of infectious diseases and for use in oncology; Medicinal preparations for sepsis, cancer, intestinal disorders, obseity and metabolic disorders; Medicinal roots; Medicinal tea used for the treatment of intestinal disorders and cancer; Medicines for alleviating constipation; Medicines for dental purposes; Medicines for intestinal disorders; Medicines for the treatment of gastrointestinal diseases; Nutritional and dietary supplements formed and packaged as bars; Nutritional food additives for medical purposes in the nature of natural food extracts derived from plants, animals, recombinant proteins and probiotics secretions; Nutritional meal replacement bars adapted for medical use for individuals undergoing medical treatments; Nutritional supplement energy bars; Nutritional supplement for eliminating toxins from the body; Nutritional supplement for eliminating toxins from the intestinal tract; Nutritional supplement in the nature of a nutrient-dense, protein-based drink mix; Nutritional supplement meal replacement bars for boosting energy; Nutritional supplement shakes; Nutritional supplements; Nutritional supplements consisting primarily of baterial detoxification enzymes and proteins; Nutritional supplements for baterial detoxification enzymes; Nutritional supplements for intestinal disorders, metabolic disorders, obseity and cancer; Nutritional supplements in capsule form for dogs; Nutritional supplements in lotion form sold as a component of nutritional skin care products; Nutritional supplements in the form of capsules, tablets, syrups, entry coated tablets and capsules, protein shakes, yogurts and energy bars; Nutritional supplements in the nature of nutritionally fortified soft chews; Nutritional supplements, namely, carbohydrates in powdered form; Nutritionally fortified beverages for medical purposes; Nutritionally fortified water for medical purposes; Nutritive substances for micro-organisms for medical use; Nutritive substances for microorganism cultures; Nutritive substances for microorganisms for medical purposes; Prebiotic supplements; Probiotic animal feed; Probiotic preparations for medical use; Probiotic supplements; Protein arrays for diagnosing sepsis, cancer, intestinal disorders, obseity and metabolic disorders; Protein dietary supplements; Protein supplement shakes; Protein supplements; Protein supplements for animals; Amino acids for nutritional purposes; Animal feed additive for use as a nutritional supplement for medical purposes; Animal feed additives for use as nutritional supplements; Bacteriostats for medicinal, dental and veterinary use; Beverages containing chlorophyll for use as a nutritional supplement; Beverages containing enzyme and proteins for use as a nutritional supplement; Bone morphogenetic protein for use as a bone growth media; Confectionery for medicinal purposes; Delivery agents in the form of capsules, tablets, syrups, entry coated tablets and capsules, protein shakes, yogurts and energy bars that facilitate the delivery of nutritional supplements; Diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; Dietary and nutritional supplements; Dietary and nutritional supplements containing baterial detoxification enzymes; Dietary and nutritional supplements for endurance sports; Dietary and nutritional supplements for baterial detoxification enzymes; Dietary and nutritional supplements used for weight loss; Fungal extracts sold as a component ingredient of nutritional supplements and vitamins; Herbs for medicinal purposes; Implantable subcutaneous drug delivery devices sold filled with pharmaceutical preparations for protein and antibodies delivery; Intravenous fluids used for rehydration, nutrition and the delivery of pharmaceutical preparations; Ketogenic dietary and nutritional supplements; Ketogenic dietary and nutritional supplements used for weight loss; Liquid nutritional supplement; Liquid protein supplements; Mineral nutritional supplements; Mineral, vitamin, or nutritionally enhanced water for medical purposes; Non-medicated additives for animal feed for use as nutritional supplements; Nopal cactus juice for use as a nutritional supplement; Nutritional supplements, namely, probiotic compositions; Pharmaceutical preparations, namely, a blood clotting aid and delivery system for use in human and veterinary medicine; Powdered nutritional supplement concentrate; Powdered nutritional supplement drink mix; Powdered nutritional supplement drink mix and concentrate; Powdered nutritional supplement drink mix containing probiotics with detoxification enzymes; Preparations for detecting mutation in prion genes for medical purposes; Prescription and non-prescription medicines, namely, pills, tablets, capsules, caplets, liquid drops, sachets and pharmaceutical preparations for the treatment of cardiovascular disorders; Soy protein dietary supplements; Soy protein for use as a nutritional supplement in various powdered and ready-to-drink beverages; Synthetic peptides for the treatment of bacterial detoxification and metabolic disorders and oncology; Transdermal patches featuring protein and antibodies delivery; Vegan protein for use as a nutritional supplement in ready-to-drink beverages; Vegan liquid protein supplements; Whey protein supplements | ACTIVE | Jan 3, 2019 |
| 040 | Chemical distillery services; Consultation in the field of clandestine drug lab site decontamination; Custom manufacture of pharmaceuticals and nutritional supplements used for detoxification of bacterial toxins by pharmaceutical compounders; Decontamination of illegal clandestine drug lab sites; Processing of medicinal plants | ACTIVE | Jan 3, 2019 |
| 042 | Chemical analysis; Chemical engineering; Chemical laboratories; Chemical research; DNA analysis services for scientific research purposes; DNA analysis services to determine paternity; DNA screening for scientific research purposes; Drug discovery services; Drug, alcohol and DNA screening for forensic research purposes; Basic and clinical research in the field of respiratory science and medicine; Conducting scientific research in the field of medicines and drug development and discovery at animal sanctuary facilities; Development of pharmaceutical preparations and medicines; Evaluation and testing of illegal clandestine drug lab sites for the presence of hazardous and illegal materials; Executing of chemical analyses; Performance of chemical analyses; Pharmaceutical drug development services; Providing a website featuring information about investigational medical devices, diagnostics and drugs; Providing laboratory research services in the field of gene expression, namely, cancer biology; Research and development of vaccines and medicines; Research and development services in the field of antibodies; Scientific study and research in the field(s) of Medicine; Testing, inspection, research, or development of pharmaceutical preparations for gene therapy | ACTIVE | Jan 3, 2019 |
| 044 | DNA screening for medical purposes; Drug testing for substance abuse; Drug testing of participants in sports for the use of illegal or prohibited performance enhancing substances; Drug use screening services; Drug use testing services; Drug, alcohol and DNA screening for medical purposes; Gene bank services; Nutrition counseling; Nutritional therapy services; Advisory services relating to nutrition; Agricultural advice, namely, providing recommendations for plant and soil nutrition supplements; Alternative medicine services; Alternative medicine services, namely, detoxification services; Consulting services in the fields of diagnostic medical testing and nutrition; Consulting services in the fields of health and nutrition; Counseling services in the fields of health, nutrition and lifestyle wellness; Dietary and nutritional guidance; Emergency medicine clinics; Food nutrition consultation; Information in the field of parenting concerning drug and alcohol abuse and addiction; Medical clinic providing weight loss solutions, services and programs, nutrition counseling, hormone therapy, including, bioidentical hormone replacement, anti aging therapy, and natural hormone therapy, medical aesthetic procedures, including, laser hair removal, laser peels, botulinum toxin treatments, microdermabrasion, liposuction, vein treatments, vein therapy, cellulite treatments, body contouring treatments, injectable filler treatments, facials, and skin care; Medical services, namely, pre-employment drug screening; Providing nutritional information about drinks; Providing nutritional information about food; Providing a web site featuring educational information regarding nutrition and genetics; Providing a web site featuring information on health and nutrition; Providing a web site that features information on children's nutrition; Providing a website featuring information about nutrition; Providing a website featuring information about health, wellness and nutrition; Providing an on-line computer database featuring information regarding health and nutrition; Providing healthy lifestyle and nutrition services, namely, personal assessments, personalized routines, maintenance schedules, and counseling; Providing information about dietary supplements and nutrition; Providing information in the field of nutrition; Providing information in the fields of animals and pet breeding, selection of the animals and pets, grooming, health and nutrition; Providing information, news and commentary in the field of nutrition, health and wellness; Providing medical information to patients and medical professionals in the form of reports in the field of medical treatment of and medcines for a wide variety of human disorders; Providing medical testing of fitness and medical consultations to assist employees in making health, wellness and nutritional changes in their daily living to increase productivity and lower health care costs for businesses; Providing medical testing of fitness and medical consultations to corporate clients to help their employees make health, wellness and nutritional changes in their daily living to improve health; Providing medical testing of fitness and medical consultations to individuals to help them make health, wellness and nutritional changes in their daily living to improve health; Providing on-line information via the Internet in the fields of animals and pets, relating to breeding, selection of the animals and pets, grooming, feeding and nutrition; Rehabilitation of drug addicted patients | ACTIVE | Jan 3, 2019 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Ramasamy, Sundaram
- Other trademarks owned by Ramasamy, Sundaram
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 040
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named RHOGEN BIOTECH
- Prosecution event MAB2 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 24, 2020 | MAB2 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Nov 24, 2020 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| May 13, 2020 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 13, 2020 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 13, 2020 | CNRT | SU - NON-FINAL ACTION - WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 20, 2020 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Apr 20, 2020 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Apr 6, 2020 | IUAF | USE AMENDMENT FILED | — |
| Apr 6, 2020 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Oct 8, 2019 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Aug 13, 2019 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Aug 13, 2019 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 24, 2019 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jul 2, 2019 | ALIE | ASSIGNED TO LIE | — |
| Jun 24, 2019 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 24, 2019 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 22, 2019 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 22, 2019 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 18, 2019 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 18, 2019 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 18, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 17, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 24, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 10, 2019 | NWAP | NEW APPLICATION ENTERED | — |